Literature DB >> 21524243

Resveratrol and its analogues: promising antitumor agents.

Xianfeng Huang1, Hai-Liang Zhu.   

Abstract

Resveratrol, a well-known natural product and a major component in grape, has attracted considerable attention as one of the most promising cancer during the past decade. Many studies have established that resveratrol can exert a broad range of biological activities including ceramide-mediated proapoptotic, antineoplastic, apoptosis-inducing, etc. Most important, resveratrol has been identified as an effective candidate for cancer chemoprevention based on its striking inhibitory effects on cellular events associated with cancer initiation, promotion, and progression. This review describes the general properties of resveratrol and its potential effect against cancer including its evidences as an antitumor agent in vitro, in vivo and clinically. In addition, we also summarized the structure-activity relationship of resveratrol and its analogues regarding the antitumor effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21524243     DOI: 10.2174/187152011795677427

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  19 in total

1.  Resveratrol mitigates genotoxicity induced by iodine-131 in primary human lymphocytes.

Authors:  Monireh Hedayati; Nayereh Shafaghati; Seyed Jalal Hosseinimehr
Journal:  Radiat Environ Biophys       Date:  2013-02-23       Impact factor: 1.925

2.  4'-Bromo-resveratrol, a dual Sirtuin-1 and Sirtuin-3 inhibitor, inhibits melanoma cell growth through mitochondrial metabolic reprogramming.

Authors:  Jasmine George; Minakshi Nihal; Chandra K Singh; Nihal Ahmad
Journal:  Mol Carcinog       Date:  2019-07-10       Impact factor: 4.784

3.  Purification and activity characterization of polysaccharides in the medicinal lichen Umbilicaria tornata from Taibai Mountain, China.

Authors:  Jiao Shang; Minfeng Fang; Li Zhang; Hui Wang; Guiping Gong; Zhongfu Wang; Ajing Zhao; Huihui Yi
Journal:  Glycoconj J       Date:  2017-12-02       Impact factor: 2.916

4.  Synergic effects of artemisinin and resveratrol in cancer cells.

Authors:  Peichun Li; Sen Yang; Mengmeng Dou; Youran Chen; Jie Zhang; Xiaoyan Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-22       Impact factor: 4.553

5.  Resveratrol inhibits the migration, invasion and epithelial-mesenchymal transition in liver cancer cells through up- miR-186-5p expression.

Authors:  Feifeng Song; Yiwen Zhang; Zongfu Pan; Qi Zhang; Xixuan Lu; Ping Huang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-10-25

6.  Regulatory effects of resveratrol on antioxidant enzymes: a mechanism of growth inhibition and apoptosis induction in cancer cells.

Authors:  Md Asaduzzaman Khan; Han-Chun Chen; Xin-Xing Wan; Mousumi Tania; Ai-Hua Xu; Fang-Zhi Chen; Dian-Zheng Zhang
Journal:  Mol Cells       Date:  2013-02-26       Impact factor: 5.034

Review 7.  Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Authors:  Poyil Pratheeshkumar; Chakkenchath Sreekala; Zhuo Zhang; Amit Budhraja; Songze Ding; Young-Ok Son; Xin Wang; Andrew Hitron; Kim Hyun-Jung; Lei Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

Review 8.  Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer.

Authors:  Samia S Messeha; Najla O Zarmouh; Karam F A Soliman
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

9.  Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways.

Authors:  Chi-Ming Chan; Hsun-Hsien Chang; Vin-Chi Wang; Chuen-Lin Huang; Chi-Feng Hung
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

10.  Effect of dietary resveratrol on the metabolic profile of nutrients in obese OLETF rats.

Authors:  Koji Nagao; Tomoyuki Jinnouchi; Shunichi Kai; Teruyoshi Yanagita
Journal:  Lipids Health Dis       Date:  2013-02-04       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.